Board MeetingJun 25, 2026, 08:01 AM
Lyell Immunopharma to Participate in H.C. Wainwright Virtual Conference
AI Summary
Lyell Immunopharma, Inc. announced that its senior management team will participate in a fireside chat at the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 30, 2026, at 1:30 pm ET. A live webcast and replay of the event will be accessible via the Investors section of the company's website. Lyell is focused on advancing next-generation CAR T-cell therapies for cancer.
Key Highlights
- Lyell Immunopharma senior management to participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference.
- Fireside chat scheduled for Tuesday, June 30, 2026, at 1:30 pm Eastern Time.
- Live webcast and replay will be available on the Investors section of the company's website.
- Lyell is a late-stage clinical company developing next-generation CAR T-cell therapies for cancer.
- LyFE manufacturing facility is expected to produce over 1,200 CAR T-cell doses annually.
Price Impact
More from LYEL